Power Law company profile

Treeline Biosciences

Biotech & Life Sciences · Stamford, United States · Founded 2021 Unicorn

Aspires to build transformative precision medicines for patients with cancer and other serious conditions

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

13 investors on Treeline Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 13 investors entered at this stage

KKR

ARCH Venture Partners

T. Rowe Price

Access Industries

Rock Springs Capital

Fidelity Investments

OrbiMed

Aisling Capital

Casdin Capital

Exor

AI Life Sciences Investments

Ajax Health

Global footprint

Where Treeline Biosciences has talent and traffic

AI talent share

1.8% of workforce is AI talent
(3 of 164 staff)

Core AI10.61%

Other AI21.22%

Non-AI workforce16198.17%

Workforce by country

4 countries with
team presence

🇺🇸 United States94.4%

🇨🇭 Switzerland2.8%

🇸🇪 Sweden2%

🇫🇷 France0.8%

4 countries shown

Web traffic by country

3.8K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$493k patent portfolio · 26 active families

Estimated portfolio value

$493k

0.02% of valuation · 46.9× smaller than top peer SpringWorks Therapeutics ($23M)

26 active patent families

Where Treeline Biosciences innovates CarcinosisChemical compoundPharmaceutical medicineCancer researchTetrahydroisoquinoline

Where Treeline Biosciences concentrates vs peers

Each axis is a top-10 topic across Treeline Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Treeline Biosciences

An AI-synthesized read of the highest-engagement posts about Treeline Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Treeline Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles